SCHEMBL690767

SCHEMBL690767

COc1c(N)cc(C(C)(C)C)cc1N[S+](C)[O-]

nearest known ligand 0.31

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31
RECQL P46063 1/20 0.31
KMT2A Q03164 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14404284 0.87 CFTR (0.36) MEN1ALDH1A1GAAMAPTKMT2A
SCHEMBL690766 0.79 GSK3A (0.36) MEN1ALDH1A1MAPTKMT2A
SCHEMBL10233040 0.79 MAPT (0.39) MEN1ALDH1A1GAAMAPTPKM
SCHEMBL689550 0.78 POLB (0.34) MEN1ALDH1A1GAAMAPTPKM
SCHEMBL690103 0.76 POLB (0.44) MEN1ALDH1A1GAAMAPTPKM
SCHEMBL15371211 0.75 MEN1 (0.36) MEN1ALDH1A1GAAMAPTPKM
SCHEMBL18873696 0.75 BRAF (0.42) MEN1ALDH1A1MAPTKMT2APOLB
Hydrochloric Acid SCHEMBL11874645 0.74 POLB (0.48) MEN1ALDH1A1GAAMAPTPKM
SCHEMBL12809304 0.74 MEN1 (0.32) MEN1ALDH1A1GAAMAPTPKM
SCHEMBL690694 0.73 MEN1 (0.31) MEN1ALDH1A1GAAMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2323980-B1 7-(PIPERAZINE-1-YMETHYL)-1H-INDOLE-2-CARBOXYLIC ACID (PHENYL)-AMIDE DERIVATIVES AND ALLIED COMPOUNDS AS P38 MAP KINASE INHIBITORS FOR THE TREATMENT OF RESPIRATORY DISEASES BOEHRINGER INGELHEIM INT (DE) 2012-02-29 EP claimed
WO-2017108736-A1 N-[3-(3-{4-[[1,2,4]TRIAZOLO[4,3-A]PYRIDIN-6-YLOXY]-1,2,3,4-TETRAHYDRO-NAPHTHALEN-1-YL} -UREIDO)-PHENYL]-METHANESULFONAMIDE DERIVATIVES AND THEIR USE AS P38 MAPK INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2017-06-29 WO disclosed